Atrial Fibrillation – from atrial extrasystoles to atrial cardiomyopathy
What have we learned from basic science and interventional procedures?

Atrial fibrillation is clinically important because it is associated with reduced quality of life and contributes to the incidence of heart failure, stroke, and cardiovascular mortality, all of which are powerful cost drivers. While survival rates of other cardiovascular disease states have improved, the prevalence of atrial fibrillation is increasing.

Despite many years of research, a precise understanding of atrial fibrillation with regard to its mechanism, relation to other cardiovascular diseases and its propensity to progression, has remained a challenge. New atria specific antiarrhythmic agents, novel anticoagulants and alternative mechanistic approaches for more effective ablation interventions have developed or are being explored.

It is therefore important to encourage scientists and clinicians to further research that may lead to important innovative approaches for the prevention and treatment of AF. The Journal of Internal Medicine has a long-standing tradition in organizing scientific Symposia on topics of major scientific importance.

The aim of the meeting is to present and discuss the most recent developments of atrial fibrillation and to exchange state-of-the-art information. The most prominent scientists in this field will give their views on both clinical and experimental aspects of mechanism and novel therapeutic strategies. Internists, general practitioners and cardiologists, and all health care providers involved in the care of patients with atrial fibrillation are cordially welcome to participate!

Carina Blomström Lundqvist guest editor for the Journal of Internal Medicine